跳至主要内容
临床试验/NL-OMON38958
NL-OMON38958已完成不适用

ong-term clinical follow-up study of patients and families with choroideremia for future clinical trials - Follow-up choroideremia

Academisch Medisch Centrum0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients who are diagnosed with choroideremia based on ophthalmologic examination by an ophthalmologist and (often) confirmed by DNA-analysis. Patients were included if they are male gender, aged *18 years of age and able to provide written informed consent.

排除标准

  • There are no exclusion criteria.

研究者

相似试验

进行中(未招募)
1 期
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19Advanced lymphoid malignanciesMedDRA version: 20.0Level: LLTClassification code 10060390Term: Leukaemia lymphoblastic acuteSystem Organ Class: 100000004864
EUCTR2016-000297-38-BEInstitut de Recherches Internationales Servier (I.R.I.S)200
进行中(未招募)
1 期
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19Advanced lymphoid malignanciesMedDRA version: 20.0Level: LLTClassification code 10060390Term: Leukaemia lymphoblastic acuteSystem Organ Class: 100000004864
EUCTR2016-000297-38-FRInstitut de Recherches Internationales Servier (I.R.I.S)200
进行中(未招募)
1 期
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19Advanced lymphoid malignanciesMedDRA version: 20.0 Level: LLT Classification code 10060390 Term: Leukaemia lymphoblastic acute System Organ Class: 100000004864
EUCTR2016-000297-38-ESInstitut de Recherches Internationales Servier (I.R.I.S)200
招募中
不适用
ong-term follow-up study of patients who have previouslybeen exposed to UCART19
JPRN-jRCT2013190001clinical operation department International center for therapeutic research200
进行中(未招募)
1 期
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19 or ALLO-501Advanced lymphoid malignanciesMedDRA version: 21.0Level: LLTClassification code 10060390Term: Leukaemia lymphoblastic acuteSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10008958Term: Chronic lymphocytic leukaemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2016-000297-38-GBInstitut de Recherches Internationales Servier (I.R.I.S)200